Pure Global AI
Disease / condition

Type 2 diabetes clinical trials

Free access to 679 studies10+ countriesUpdated daily140 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
679
Total trials
10+
Countries
10+
Sponsors
140
Recruiting
By phase
N/A441
Not Applicable138
Phase 447
Early Phase 128
Phase 113
By status
Completed332
Recruiting140
Not yet recruit...71
Unknown36
Recruitment Com...33
Top countries
Japan344
China129
Australia53
United Kingdom12
Netherlands11
Top sponsors
Novo Nordisk A/S12
Hokkaido Universit...9
Akishima Clinic8
Yokohama City Univ...7
National Hospital ...5
Recent trials
Latest clinical trials for Type 2 diabetes
Untitled Trial
jRCT1061230070Not yet recr...
Toranomon Walk-Training Trial Part2
Toranomon Hospital · Japan
UMIN000052441Recruitment ...
Untitled Trial
Novo Nordisk Pharma Ltd. · Argentina;Australia;Brazil;Bulgaria;Canada;China;Colombia;Croatia;Czech;Denmark;Finland;Germany;Gree
jRCT2031230369Recruiting
Comparison of insulin degludec/liraglutide versus insulin degludec in multiple daily injection therapy on subjects with type 2 diabetes; time to reach target glycemic levels
Kushiro Red Cross Hospital · Japan
UMIN000052156Recruiting
The Effect of Online App Connections on Physical Activity.
Toyooka Public Hospital · Japan
UMIN000051788Enrolling by...
Effect on blood glucose fluctuation after addition of imeglimin in patients with type 2 diabetes mellitus under pre-administration of metformin
Dokkyo Medical University · Japan
UMIN000051451Recruiting
Oral semaglutide vs DPP-4i on body weight in Japanese people with type 2 diabetes
Dokkyo Medical University Depa... · Japan
UMIN000051448Recruiting
The renal benefits of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study
Kushiro Red Cross Hospital · Japan
UMIN000051442Enrolling by...
The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study
Kushiro Red Cross Hospital · Japan
UMIN000051344Enrolling by...
Untitled Trial
jRCTs061230021Recruiting
Untitled Trial
jRCTs011230006Recruiting
Untitled Trial
National Hospital Organization
jRCT1030230057Recruitment ...
Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes
Hokkaido University Hospital · Japan
UMIN000050583Recruiting
Phase
Phase 4
Acute effect of the renally excreted low-calorie sweetener, acesulfame potassium (Ace-K), on urinary glucose excretion in people with type 2 diabetes.
The University of Adelaide · Australia
ANZCTR12623000094673Not yet recr...
Phase
Not Applicable
Evaluation of the Effect of Self-management Education in Teach Back Method on Medication and Nutritional Adherence of Elderly Patients with Type 2 Diabetes
Bojnourd University of Medical... · Iran
IRCT20221011056146N1Recruiting
Improving risk communication in Type 2 diabetics to initiate self-management behaviour change
Department of General Practice... · Japan
UMIN000049643Enrolling by...
Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products
Akishima Clinic · Japan
UMIN000049408Completed
Investigation of the efficacy of Imeglimin on glycemic control and the underlying mechanisms
Toho university · Japan
UMIN000049203Not yet recr...
A study on changes in glycemic control in patients with type 2 diabetes using food delivery service
Respiratory Medicine, Miyazaki... · Japan
UMIN000049094Completed
Untitled Trial
jRCTs052220099Completed
About this profile

Access comprehensive clinical trial information for Type 2 diabetes through Pure Global AI's free database. This collection includes 679 clinical trials across multiple phases including N/A, Not Applicable, Phase 4. Currently, 140 trials are actively recruiting participants.

Research for Type 2 diabetes is being conducted in Japan, China, Australia and 7+ other countries. Leading sponsors include Novo Nordisk A/S and Hokkaido University Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 679 clinical trials studying Type 2 diabetes, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Novo Nordisk A/S, Hokkaido University Hospital, Akishima Clinic, among others.